STOCKHOLM, July 31,
2024 /PRNewswire/ -- During July, the number of
shares and votes in Calliditas Therapeutics AB (publ) has
changed due to the exercise of warrants under the company's
long-term incentive program issued in 2020, ESOP 2020 and Board of
Directors program LTIP 2021. As of today, the total number of
outstanding shares in Calliditas Therapeutics AB (publ) amounts to
59,941,465 ordinary shares. The number of votes in Calliditas
Therapeutics AB (publ) as of today amounts to 59,941,465. The share
capital has increased by SEK
14,455.12 from SEK
2,383,203.48 to SEK
2,397,658.60.
For further information, please contact:
Åsa Hillsten, Head of IR & Sustainability, Calliditas
Tel.: +46 76 403 35 43, Email: asa.hillsten@calliditas.com
The information in the press release is such that Calliditas
Therapeutics AB (publ) is required to disclose pursuant to the
Swedish Financial Instruments Trading Act. The information was
submitted for publication, through the agency of the contact
persons set out above, at 2 p.m. CEST
on July 31, 2024.
About Calliditas
Calliditas Therapeutics is a commercial stage biopharma company
based in Stockholm, Sweden focused
on identifying, developing and commercializing novel treatments in
orphan indications, with an initial focus on renal and hepatic
diseases with significant unmet medical needs. Calliditas' common
shares are listed on Nasdaq Stockholm (ticker: CALTX) and its
American Depositary Shares are listed on the Nasdaq Global Select
Market (ticker: CALT).
This information was brought to you by Cision
http://news.cision.com
https://news.cision.com/calliditas-therapeutics/r/number-of-shares-and-votes-in-calliditas-therapeutics,c4018656
The following files are available for download:
|
https://mb.cision.com/Main/16574/4018656/2926878.pdf
|
Number of shares and
votes July 2024 (Eng)
|
View original
content:https://www.prnewswire.com/news-releases/number-of-shares-and-votes-in-calliditas-therapeutics-302211062.html
SOURCE Calliditas Therapeutics